Insider Trading History of Browne Leslie J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Browne Leslie J since 2005. The trader's CIK number is 1300293. At the time of the last reporting, Browne Leslie J was the President and CEO of Eloxx Pharmaceuticals, Inc.. (stock ticker symbol ELOX). Also see all insider trading activities at Eloxx Pharmaceuticals, Inc..

Note that in the past Browne Leslie J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pharmacopeia Drug Discovery Inc (PCOP) by Browne Leslie J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 PCOP 2,000 $8,980 0 $0 0 $0
2005 PCOP 500 $2,400 0 $0 0 $0

Yearly summary of insider trading at Eloxx Pharmaceuticals, Inc. (SNTI) by Browne Leslie J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 SNTI 30,800 $4,520 0 $0 0 $0
2012 SNTI 10,000 $2,600 0 $0 0 $0
2011 SNTI 9,000 $2,521 0 $0 0 $0


Insider trading activities at 2 companies by Browne Leslie J:

1. Pharmacopeia Drug Discovery Inc (PCOP)

2. Eloxx Pharmaceuticals, Inc. (SNTI)

Table 1. Insider trading of Pharmacopeia Drug Discovery Inc (PCOP) by Browne Leslie J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-12-05 PCOP Buy 1,000 4.46 4,455
2007-12-06 PCOP Buy 500 4.55 2,275
2007-12-07 PCOP Buy 500 4.50 2,250
2005-06-06 PCOP Buy 500 4.80 2,400

Table 2. Insider trading of Eloxx Pharmaceuticals, Inc. (SNTI) by Browne Leslie J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-12-19 SNTI Buy 800 4.15 3,320
2013-05-20 SNTI Buy 30,000 .04 1,200
2012-03-29 SNT Buy 10,000 .26 2,600
2011-03-21 SNT Buy 3,000 .27 804
2011-02-23 SNT Buy 3,000 .28 854
2011-02-24 SNT Buy 3,000 .29 863

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Browne Leslie J (President and CEO of Eloxx Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.